T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies

Author： Garrido Greta Lorenzano Pablo Sánchez Belinda Beausoleil Irene Alonso Daniel Pérez Rolando Fernández Luis

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.56, Iss.11, 2007-11, pp. : 1701-1710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite

Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer

By Waksal H.W.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 427-436

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies for Advanced Breast Cancer

By Campos Susana

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 757-768

Informa Healthcare

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 5, 2003-09 ,pp. : 327-333

Bentham Science Publishers

Access to resources Recommend Favorite

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1799-1807

Spandidos Publications

Access to resources Recommend Favorite